Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Plasmapheresis on Clinical Improvement and Biological Parameters of Patients With Long-haul COVID: PLEXCOVIL Study, a Randomized Controlled Study.

NCT05543590 is registered in ClinicalTrials.gov with Hôpital Européen Marseille as lead sponsor.

NCT NCT05543590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05543590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Plasmapheresis on Clinical Improvement and Biological Parameters of Patients With Long-haul COVID: PLEXCOVIL Study, a Randomized Controlled Study.
Lead sponsor
Hôpital Européen Marseille
Phase
Not applicable
Overall status
Withdrawn
Start date
February 28, 2023
Completion date
October 31, 2025
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

long-haul covid-19